These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 27807061)
21. Targeted DNA Sequencing Detects Mutations Related to Susceptibility among Familial Non-medullary Thyroid Cancer. Yu Y; Dong L; Li D; Chuai S; Wu Z; Zheng X; Cheng Y; Han L; Yu J; Gao M Sci Rep; 2015 Nov; 5():16129. PubMed ID: 26530882 [TBL] [Abstract][Full Text] [Related]
22. Frequent and Rare HABP2 Variants Are Not Associated with Increased Susceptibility to Familial Nonmedullary Thyroid Carcinoma in the Spanish Population. de Randamie R; Martos-Moreno GÁ; Lumbreras C; Chueca M; Donnay S; Luque M; Regojo RM; Mendiola M; Hardisson D; Argente J; Moreno JC Horm Res Paediatr; 2018; 89(6):397-407. PubMed ID: 29895015 [TBL] [Abstract][Full Text] [Related]
23. Familial non-medullary thyroid carcinoma: an update. Nosé V Endocr Pathol; 2008; 19(4):226-40. PubMed ID: 18931957 [TBL] [Abstract][Full Text] [Related]
29. Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma. Ye F; Gao H; Xiao L; Zuo Z; Liu Y; Zhao Q; Chen H; Feng W; Fu B; Sun L; Jiang X; He D; Jiang H; Yang M; Li L; Chen F; Liu X; Li S; Li Z; Jiang Y; Cheng L; Bu H Int J Cancer; 2019 Mar; 144(6):1321-1330. PubMed ID: 30132833 [TBL] [Abstract][Full Text] [Related]
31. Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer. McKay JD; Thompson D; Lesueur F; Stankov K; Pastore A; Watfah C; Strolz S; Riccabona G; Moncayo R; Romeo G; Goldgar DE J Med Genet; 2004 Jun; 41(6):407-12. PubMed ID: 15173224 [TBL] [Abstract][Full Text] [Related]
32. Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Moses W; Weng J; Kebebew E Thyroid; 2011 Apr; 21(4):367-71. PubMed ID: 21190444 [TBL] [Abstract][Full Text] [Related]
33. Novel Susceptibility Genes Drive Familial Non-Medullary Thyroid Cancer in a Large Consanguineous Kindred. Majdalani P; Yoel U; Nasasra T; Fraenkel M; Haim A; Loewenthal N; Zarivach R; Hershkovitz E; Parvari R Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175943 [TBL] [Abstract][Full Text] [Related]
34. [Hereditary predispositions to follicular thyroid tumors]. Decaussin-Petrucci M Ann Pathol; 2020 Apr; 40(2):142-147. PubMed ID: 32192806 [TBL] [Abstract][Full Text] [Related]
35. Chromosomal localization of mutated genes in non-syndromic familial thyroid cancer. Jiang YJ; Xia Y; Han ZJ; Hu YX; Huang T Front Oncol; 2024; 14():1286426. PubMed ID: 38571492 [TBL] [Abstract][Full Text] [Related]
36. Identification of susceptibility gene mutations associated with the pathogenesis of familial nonmedullary thyroid cancer. Zhu J; Wu K; Lin Z; Bai S; Wu J; Li P; Xue H; Du J; Shen B; Wang H; Liu Y Mol Genet Genomic Med; 2019 Dec; 7(12):e1015. PubMed ID: 31642198 [TBL] [Abstract][Full Text] [Related]
38. CHEK2 germline variants identified in familial nonmedullary thyroid cancer lead to impaired protein structure and function. Pires C; Marques IJ; Valério M; Saramago A; Santo PE; Santos S; Silva M; Moura MM; Matos J; Pereira T; Cabrera R; Lousa D; Leite V; Bandeiras TM; Vicente JB; Cavaco BM J Biol Chem; 2024 Mar; 300(3):105767. PubMed ID: 38367672 [TBL] [Abstract][Full Text] [Related]
39. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma. Bonora E; Rizzato C; Diquigiovanni C; Oudot-Mellakh T; Campa D; Vargiolu M; Guedj M; ; McKay JD; Romeo G; Canzian F; Lesueur F Int J Cancer; 2014 May; 134(9):2098-107. PubMed ID: 24127282 [TBL] [Abstract][Full Text] [Related]
40. The familial counterparts of follicular cell--derived thyroid tumors. Prazeres H; Torres J; Soares P; Sobrinho-Simões M Int J Surg Pathol; 2010 Aug; 18(4):233-42. PubMed ID: 20444727 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]